药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Alirocumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Alirocumab.
Econazole
Idarucizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Idarucizumab.
Econazole
Asfotase alfa
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Asfotase alfa.
Econazole
Dulaglutide
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Dulaglutide.
Econazole
Pembrolizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pembrolizumab.
Econazole
Nivolumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Nivolumab.
Econazole
Raxibacumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Raxibacumab.
Econazole
Ofatumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ofatumumab.
Econazole
Volociximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Volociximab.
Econazole
Catumaxomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Catumaxomab.
Econazole
Teplizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Teplizumab.
Econazole
Reslizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Reslizumab.
Econazole
Lexatumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lexatumumab.
Econazole
Lerdelimumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lerdelimumab.
Econazole
Bivatuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bivatuzumab.
Econazole
Sibrotuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Sibrotuzumab.
Econazole
Apolizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Apolizumab.
Econazole
Siplizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Siplizumab.
Econazole
Pertuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pertuzumab.
Econazole
Lucatumumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lucatumumab.